// App-Quantinova.ai

3036 : Hematopoietic Cell Transplantation for Children with High Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Report From the Italian Association of Pediatric Hematology and Oncology (AIEOP) Registry.

Researchers

Presenter

  • Paola Quarello

Principal Investigators

  • Marco Zecca

  • Giuseppe Basso

  • Arcangelo Prete

  • Franco Locatelli

  • Edoardo Lanino

  • Carla Rognoni

  • Adriana Balduzzi

  • Chiara Messina

  • Claudio Favre

  • Roberto Foa

  • Mimmo Ripaldi

  • Sergio Rutella

Medical Centers

  • San Gerardo Hospital, Department of Pediatric Hematology, Monza, Italy

  • Paediatric Haematology / Oncology, Fondazione IRCCS, Policlinico San Matteo Foundation, Pavia, Italy,

  • Sapienza University of Rome, Department of Cellular Biotechnology and Haematology, Rome, Italy

  • Department of Pediatrics, University of Bari, Bari, Italy

  • Regina Margherita Childrens Hospital, Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Torino, Italy

  • Department of Pediatric Hematology and Oncology, Bambino Gesu Childrens Hospital, IRCCS, Rome, Italy

  • Department of Pediatric Hemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim